Published April 25, 2024 | Version 0
Output management plan Open

ThrombUS+ Data Management Plan

Authors/Creators

  • 1. PREDICTBY RESEARCH AND CONSULTING S.L., Athena Research and Innovation Center In Information Communication & Knowledge Technologies, Lithuanian University of Health Sciences, GROUPEMENT HOSPITALIER EAUBONNE MONTMORENCY SIMONE VEIL, MEDIS MEDIZINISCHE MESSTECHNIK GMBH, Technologija, Kaunas University of Technology, COMFTECH SRL, Fraunhofer Institute for Photonic Microsystems, GENIKO NOSOKOMEIO PAPAGEORGIOU, ECHONOUS INC, SCIGEN TECHNOLOGIES ANONYMI ETAIREIA PARAGOGIS LOGISMIKOU KAI ILEKTROMICHANOLOGIKON KATASKEUON, FONDAZIONE CASA SOLLIEVO DELLA SOFFERENZA, VERMON SA, VDE VERBAND DER ELEKTROTECHNIK ELEKTRONIK INFORMATIONSTECHNIK EV, UZDAROJI AKCINE BENDROVE TELEMED, TAMPEREEN KORKEAKOULUSAATIO SR, PHAZE KLINIKI EREVNA & FARMAKEFTIKES SYMVOULES ANONYMI ETAIREIA, MEDEA SRL

Contributors

  • 1. PREDICTBY RESEARCH AND CONSULTING S.L., Athena Research and Innovation Center In Information Communication & Knowledge Technologies, Lithuanian University of Health Sciences, GROUPEMENT HOSPITALIER EAUBONNE MONTMORENCY SIMONE VEIL, MEDIS MEDIZINISCHE MESSTECHNIK GMBH, Technologija, Kaunas University of Technology, COMFTECH SRL, Fraunhofer Institute for Photonic Microsystems, GENIKO NOSOKOMEIO PAPAGEORGIOU, ECHONOUS INC, SCIGEN TECHNOLOGIES ANONYMI ETAIREIA PARAGOGIS LOGISMIKOU KAI ILEKTROMICHANOLOGIKON KATASKEUON, FONDAZIONE CASA SOLLIEVO DELLA SOFFERENZA, VERMON SA, VDE VERBAND DER ELEKTROTECHNIK ELEKTRONIK INFORMATIONSTECHNIK EV, UZDAROJI AKCINE BENDROVE TELEMED, TAMPEREEN KORKEAKOULUSAATIO SR, PHAZE KLINIKI EREVNA & FARMAKEFTIKES SYMVOULES ANONYMI ETAIREIA, MEDEA SRL

Description

ThrombUS+ brings together an interdisciplinary team of industrial, technology, regulatory, social science and clinical trial experts to develop a novel wearable diagnostic device for point-of-care, operator free, continuous monitoring in patients with high DVT risk. The device will combine autonomous, AI driven DVT detection based on a novel wearable ultrasound hardware, impedance plethysmography and light reflection rheography for immediate detection of blood clot formation in the lower limb. Activity and other physiological measurements will be used to provide a continuous assessment of DVT risk and support DVT prevention via serious gaming. The aggregated data will drive an intelligence decision support unit that will provide accurate monitoring and alerts. Extended reality will be used to guide experts to design exercises and patients to use the device optimally. Various data sets, including ultrasound images from five clinical studies will be collected during the ThrombUS+. This document serves as the Data Managment Plan for all these data sets. 

ThrombUS+ project:
Grant Agreement: 101137227
Start date: January 1st, 2024
End date: June 30th, 2027

Files

DMP_ThrombUS+_Wearable_Continuous_PointofCare_Monitoring_Risk_Estimation_and_Prevention_for_Deep_Vein_Thrombosis_0.pdf

Additional details

Funding

European Commission
ThrombUS - ThrombUS+: Wearable Continuous Point-of-Care Monitoring, Risk Estimation and Prevention for Deep Vein Thrombosis 101137227